Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin.

Santantonio T, Fasano M, Sagnelli E, Tundo P, Babudieri S, Fabris P, Toti M, Di Perri G, Marino N, Pizzigallo E, Angarano G; Acute Hepatitis C Study Group.

Hepatology. 2014 Jun;59(6):2101-9. doi: 10.1002/hep.26991. Epub 2014 Apr 29.

PMID:
24442928
[PubMed - indexed for MEDLINE]
2.

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862.

PMID:
18461712
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292.

PMID:
18387667
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population.

Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, Tramarin A, Tositti G, Floreani A.

J Clin Gastroenterol. 2008 May-Jun;42(5):527-32. doi: 10.1097/MCG.0b013e318030e3ab.

PMID:
18277889
[PubMed - indexed for MEDLINE]
5.

Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis.

Cicconi P, Cozzi-lepri A, Orlando G, Matteelli A, Girardi E, Degli Esposti A, Moioli C, Rizzardini G, Chiodera A, Ballardini G, Tincati C, d'Arminio Monforte A; I.Co.N.A. Study Group.

Infection. 2008 Feb;36(1):46-53. doi: 10.1007/s15010-007-6300-z. Epub 2008 Jan 29.

PMID:
18231722
[PubMed - indexed for MEDLINE]
6.

Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

Cicconi P, Cozzi-Lepri A, Phillips A, Puoti M, Antonucci G, Manconi PE, Tositti G, Colangeli V, Lichtner M, Monforte Ad; ICoNA Study Group.

AIDS. 2007 Mar 12;21(5):599-606.

PMID:
17314522
[PubMed - indexed for MEDLINE]
7.

Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C.

Tommasi AM, Fabris P, Carderi I, Baragiotta A, Baldo V, Venturi C, Giordani MT, Tositti G, Floreani A.

J Clin Gastroenterol. 2006 May-Jun;40(5):440-3.

PMID:
16721228
[PubMed - indexed for MEDLINE]
8.

Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle.

Fabris P, Tositti G, Giordani MT, Baldo V, Grasso A, Pignattari E, Canton S, Rossato S, Floreani A.

Aliment Pharmacol Ther. 2006 Apr 15;23(8):1161-70.

PMID:
16611277
[PubMed - indexed for MEDLINE]
Free Article
9.

Human leptospirosis in the Vicenza area (Italy) from 1990 to 2003: an epidemiological and clinical study.

Conti E, Lazzarini L, Reatto P, Tositti G, de Lalla F.

Infez Med. 2005 Dec;13(4):235-40.

PMID:
16388279
[PubMed - indexed for MEDLINE]
Free Article
10.

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study.

Murri R, Lepri AC, Cicconi P, Poggio A, Arlotti M, Tositti G, Santoro D, Soranzo ML, Rizzardini G, Colangeli V, Montroni M, Monforte AD; ICoNA Study Group.

J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):23-30.

PMID:
16340469
[PubMed - indexed for MEDLINE]
11.

Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital.

Lazzarini L, Conti E, Tositti G, de Lalla F.

J Infect. 2005 Dec;51(5):383-9.

PMID:
16321649
[PubMed - indexed for MEDLINE]
12.

Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile.

Tositti G, Rassu M, Fabris P, Giordani M, Cazzavillan S, Reatto P, Zoppelletto M, Bonoldi M, Baldo V, Manfrin V, de Lalla F.

HIV Med. 2005 Jan;6(1):27-32.

PMID:
15670249
[PubMed - indexed for MEDLINE]
13.

Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems.

De Luca A, Cozzi-Lepri A, Perno CF, Balotta C, Di Giambenedetto S, Poggio A, Pagano G, Tositti G, Piscopo R, Del Forno A, Chiodo F, Magnani G, d'Arminio Monforte A; ICoNA drug resistance study group; ICoNA study group.

Antivir Ther. 2004 Oct;9(5):743-52.

PMID:
15535412
[PubMed - indexed for MEDLINE]
14.

A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone.

Fattovich G, Zagni I, Ribero ML, Castagnetti E, Minola E, Lomonaco L, Scattolini C, Fabris P, Boccia S, Giusti M, Abbati G, Felder M, Rovere P, Redaelli A, Tonon A, Tomba A, Montanari R, Paternoster C, Distasi M, Fornaciari G, Tositti G, Rizzo C, Suppressa S, Pantalena M, Noventa F, Tagger A.

J Viral Hepat. 2004 Nov;11(6):543-51.

PMID:
15500555
[PubMed - indexed for MEDLINE]
15.

Can we really identify HIV-1 long-term nonprogressors?

Vento S, Lanzafame M, Malena M, Tositti G, Cainelli F, Concia E, Masiero G.

J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1218-9. No abstract available.

PMID:
15319684
[PubMed - indexed for MEDLINE]
16.

Therapy of chronic hepatitis C virus infection in HIV co-infected people.

Fabris P, Barnes E, Tositti G, Giordani MT, Grasso A, De Lalla F.

Curr Pharm Des. 2004;10(17):2111-22. Review.

PMID:
15279550
[PubMed - indexed for MEDLINE]
17.

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.

Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT, Bevilacqua P, de Lalla F, Webster GJ, Dusheiko G.

J Clin Virol. 2004 Mar;29(3):160-6.

PMID:
14962784
[PubMed - indexed for MEDLINE]
18.

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.

Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C.

Aliment Pharmacol Ther. 2003 Sep 15;18(6):549-58. Review.

PMID:
12969081
[PubMed - indexed for MEDLINE]
Free Article
19.

Occult hepatitis B virus infection in HIV/hepatitis C virus co-infected patients.

Fabris P, Giordani MT, Tositti G, Rassu M, De Lalla F.

AIDS. 2003 Jul 4;17(10):1581-2. No abstract available.

PMID:
12824807
[PubMed - indexed for MEDLINE]
20.

Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C.

Fattovich G, Zagni I, Fornaciari G, Minola E, Fabris P, Boccia S, Giusti M, Abbati G, Felder M, Rovere P, Redaelli A, Tonon A, Montanari R, Paternoster C, Distasi M, Castagnetti E, Tositti G, Rizzo C, Suppressa S, Pantalena M, Lomonaco L, Scattolini C, Tagger A.

J Viral Hepat. 2003 Mar;10(2):111-7.

PMID:
12614467
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk